Cell Disruption Bead Milling Patents: Concentration, Trends and Open Ground
30.0% of all 300 records sit with just five assignees, yet the ranked list runs to 100 companies — a dense top with a long single-filer tail. Filings rose from 7 in 2017 to a peak of 26 in 2023, the field's highest single year so far. The 2021-to-2024 comparison — 2 records to 2 records — shows 0% net growth over that three-year span, consistent with a field that has settled into a plateau after its early build-up rather than one still accelerating.
- 1GENENTECH INC24
- 2PRESSURE BIOSCIENCES INC20
- 3OHLY GMBH20
- 4VGXI INC13
- 5DIREVO INDAL BIOTECH13
See the full cell disruption bead milling analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on cell disruption bead milling patents
Who are the leading patent holders in cell disruption bead milling?
The ranked list covers 100 companies, with the leader holding 24 of the 300 records in scope and the top five combined holding 90 records, or 30.0% of the total. Below the top ten — which together hold 46.0% of all records — filings spread thinly across many single- or low-digit filers, including academic and specialist entrants. This structure means checking any specific competitor's individual portfolio is more informative than assuming a small group controls the space.
Is patent filing in cell disruption bead milling growing or slowing down?
Filing activity peaked in 2023 at 26 records, and the comparison between 2021 (2 records) and 2024 (2 records) shows 0% net growth over that span. Because publication typically lags filing by around 18 months, the lower counts in 2025 and 2026 in this dataset should be read as still filling in rather than as evidence of a declining field. On the data available through the complete years, the field looks like a plateau rather than either sustained growth or a downturn.
What technology areas dominate cell disruption bead milling patents?
C12N, covering microorganisms and genetic engineering, appears in 94.7% of the 300 records in scope, making it by far the dominant classification. C12M (bioreactor apparatus, 27.0%) and C12P (fermentation and enzymatic synthesis, 26.3%) follow at a distance, with measurement-focused classes C12Q and G01N each near 18-19%. Because a single record can carry multiple IPC classes, these shares add up to well over 100% and should not be read as mutually exclusive categories.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Cell Disruption Bead Milling covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.